Generic drug of Pulmonary Artery Hypertension – Hurdles before Pharma Companies
Macitentan is a drug by Actelion for treating Pulmonary Arterial Hypertension (PAH). It’s popularly known as Opsumit and delays the progression of PAH, which got approval from the FDA in Dec 2013. Since then, 35 other countries have given an affirmation for its usage. After its approval, Opsumit has done great business for Actelion. In […]
How Patent Monitoring Report Can Help In Holistic Competitor Intelligence?
How far have your closest competitors come? What patents? In what countries are they valid, and for how long? Or, more specifically: What has happened in your particular technological area during the last six months? Competitive intelligence is an essential strategy, especially when monitoring a competitor’s patent portfolio. Obviously, you know your competitors. But do […]